Evidence map›Paper›PMID 29098373›Full record

ReviewSeminars in immunopathology2017

Newborn susceptibility to infection vs. disease depends on complex in vivo interactions of host and pathogen.

Byron Brook, Danny Harbeson, Rym Ben-Othman, Dorothee Viemann, Tobias R Kollmann

Abstract readReview
PubMed Publisher
In one paragraph

Review in Seminars in immunopathology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Article
  2. Priming innate immunity and long-term outcome.Molecular and cellular pediatrics · 2026
    Review
  3. Review
  4. Article
  5. Observational
  6. Article
  7. Transfusion strategies for neonates: current perspectives.Annals of medicine and surgery (2012) · 2024
    Review
  8. Article
  9. Monocytes from Uninfected Neonates Born toPathogens (Basel, Switzerland) · 2023
    Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Frontiers in microbiology · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Byron BrookDepartment of Experimental Medicine, University of British Columbia, UBC, BCCHRI A5-175, 950 W 28th Ave, Vancouver, BC, V5Z4H4, Canada.
Danny HarbesonDepartment of Experimental Medicine, University of British Columbia, UBC, BCCHRI A5-175, 950 W 28th Ave, Vancouver, BC, V5Z4H4, Canada.
Rym Ben-OthmanDepartment of Pediatrics, Division of Infectious Diseases, University of British Columbia, Vancouver, Canada.
Dorothee ViemannDepartment of Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Hannover, Germany.
Tobias R KollmannDepartment of Experimental Medicine, University of British Columbia, UBC, BCCHRI A5-175, 950 W 28th Ave, Vancouver, BC, V5Z4H4, Canada. tkollm@mac.com.

Funding

Deutsche Forschungsgemeinschaft VI 538/6-1Volkswagen Foundation Az 90005
6 · The paper itself

Abstract

The burden of newborn infectious disease has long been recognized as the highest across the entire human life span. The precise underlying cause is unfortunately still far from clear. A substantial body of data derived mostly from in vitro experimentation indicates "lower" host immune responses in early vs. adult life and is briefly summarized within this review. However, emerging data derived mostly from in vivo experimentation reveal that the newborn host also exhibits an exuberant immune and inflammatory response following infection when compared to the adult. In this context, it is important to emphasize that "infection" does not equate "infectious disease," as for many infections it is the host response to the infection that causes disease. This simple insight readily arranges existing evidence into cause-effect relationships that explain much of the increase in clinical suffering from infection in early life. We here briefly summarize the evidence in support of this paradigm and highlight the important implications it has for efforts to ameliorate the suffering and dying from infection in early life.

Indexed as

Age FactorsAnimalsDisease ResistanceDisease SusceptibilityHost-Pathogen InteractionsHumansImmunityInfant, Newborn

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.